✦ LIBER ✦

A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer

✍ Scribed by P. Savage; D. Costelna; J. Moore; M.E. Gore

Book ID: 117663708
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 278 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(96)00515-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protracted venous infusion 5-fluorouraci

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study.

✍ MJ Allen; M Vaughan; A Webb; S Johnston; P Savage; T Eisen; S Bates; J Morre; R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Phase II trial of interleukin 2, interfe

Phase II trial of interleukin 2, interferon α, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.

✍ JP Dutcher; T Logan; M Gordon; J Sosman; G Weiss; K Margolin; T Plasse; J Mier; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Interleukin-2 (IL-2), interferon-A (IFN-

Interleukin-2 (IL-2), interferon-A (IFN-A), 5-fluorouracil (5-FU) and vinblastine (VBL) for treatment of metastatic renal cell carcinoma (MRCC)

✍ E. Gez; R. Rubinov; D. Gaitini; S. Meritick; L. Best; O. Native; A. Stein; J. Zi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

150 - Subcutaneous (SC) interleukin-2 (I

150 - Subcutaneous (SC) interleukin-2 (IL-2) plus alpha interferon (IFN-α) and 5 fluorouracil (5 FU) in out-patients (pts) with metastatic renal cell carcinoma (MRCC). Scapp II trial

✍ J.M. Tourani; A. Benhammouda; P. Guillet; C. Pfister; B. Paule; J.F. Berbah; Y. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

Infusional interleukin-2 and 5-fluoroura

Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-α for the treatment of patients with advanced renal cell carcinoma : A Southwest Oncology Group Phase II study

✍ Laurence Elias; Danika Lew; Robert A. Figlin; Robert C. Flanigan; Mark E. Thomps 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views